{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:04:48Z","timestamp":1793138688533,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02742-x","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T08:02:07Z","timestamp":1684569727000},"page":"3355-3362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of thyroid hormone status on complete blood cell count-derived inflammatory biomarkers in patients with moderate-to-severe Graves\u2019 ophthalmopathy"],"prefix":"10.1007","volume":"43","author":[{"given":"Nilay","family":"Yuksel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Saritas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"2742_CR1","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1089\/thy.2012.0258","volume":"23","author":"MN Stan","year":"2013","unstructured":"Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS (2013) Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves\u2019 ophthalmopathy and optimal timing for thyroid hormone assessment. Thyroid 23:620\u2013625","journal-title":"Thyroid"},{"key":"2742_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/archinte.1990.00390170124027","volume":"150","author":"MF Prummel","year":"1990","unstructured":"Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, Van der Gaag R (1990) Effect of abnormal thyroid function on the severity of Graves\u2019 ophthalmopathy. Arch Intern Med 150:1098\u20131101","journal-title":"Arch Intern Med"},{"key":"2742_CR3","doi-asserted-by":"publisher","first-page":"10833","DOI":"10.1038\/s41598-017-11398-4","volume":"7","author":"X Hao","year":"2017","unstructured":"Hao X, Li D, Wu D, Zhang N (2017) The relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a meta-analysis. Sci Rep 7:10833","journal-title":"Sci Rep"},{"key":"2742_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","volume":"26","author":"B Qin","year":"2016","unstructured":"Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H et al (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26:372\u2013376","journal-title":"Mod Rheumatol"},{"key":"2742_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10067-014-2540-3","volume":"33","author":"S Yavuz","year":"2014","unstructured":"Yavuz S, Ece A (2014) Mean platelet volume as an indicator of disease activity in juvenile SLE. Clin Rheumatol 33:637\u2013641","journal-title":"Clin Rheumatol"},{"key":"2742_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jbspin.2007.06.016","volume":"75","author":"B Kisacik","year":"2008","unstructured":"Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA et al (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75:291\u2013294","journal-title":"Joint Bone Spine"},{"key":"2742_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/ced.14432","volume":"46","author":"E Tanacan","year":"2021","unstructured":"Tanacan E, Dincer D, Erdogan FG, Gurler A (2021) A cutoff value for the systemic immune-inflammation Index in determining activity of Beh\u00e7et disease. Clin Exp Dermatol 46:286\u2013291","journal-title":"Clin Exp Dermatol"},{"key":"2742_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/eje.0.1480491","volume":"148","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, Bakker A, Wiersinga WM et al (2003) Multicenter study on the characteristics and treatment strategies of patients with Graves\u2019 orbitopathy: the first European Group on Graves\u2019 Orbitopathy experience. Eur J Endocrinol 148:491\u2013495","journal-title":"Eur J Endocrinol"},{"key":"2742_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 47:9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2742_CR10","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, Dayan MC, Eckstein A, Marcocci C et al (2021) The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185:G43\u2013G67","journal-title":"Eur J Endocrinol"},{"key":"2742_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jcem-25-1-1","volume":"25","author":"H Aranow","year":"1965","unstructured":"Aranow H, Day RM (1965) Management of thyrotoxicosis in patients with ophthalmopathy: antithyroid regimen determined primarily by ocular manifestations. J Clin Endocrinol Metab 25:1\u201310","journal-title":"J Clin Endocrinol Metab"},{"key":"2742_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.0954-6820.1979.tb06012.x","volume":"205","author":"JH Solem","year":"1979","unstructured":"Solem JH, Segaard E, Ytteborg J (1979) The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study. Acta Med Scand 205:111\u2013114","journal-title":"Acta Med Scand"},{"key":"2742_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000135626","volume":"15","author":"AJ Klecha","year":"2008","unstructured":"Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G (2008) Immune-endocrine interactions in autoimmune thyroid diseases. NeuroImmunoModulation 15:68\u201375","journal-title":"NeuroImmunoModulation"},{"key":"2742_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","volume":"292","author":"L Bartalena","year":"2022","unstructured":"Bartalena L, Tanda ML (2022) Current concepts regarding Graves\u2019 orbitopathy. J Intern Med 292:692\u2013716","journal-title":"J Intern Med"},{"key":"2742_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13044-018-0046-9","volume":"11","author":"M Rydzewska","year":"2018","unstructured":"Rydzewska M, Jaromin M, Pasierowska IE, Stozek K, Bossowski A (2018) Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res 11:2","journal-title":"Thyroid Res"},{"key":"2742_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/ar4325","volume":"15","author":"MJ Kaplan","year":"2013","unstructured":"Kaplan MJ (2013) Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther 15:219","journal-title":"Arthritis Res Ther"},{"key":"2742_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/jth.12612","volume":"12","author":"L Zhu","year":"2014","unstructured":"Zhu L, Huang Z, St\u00e5lesen R, Hansson GK, Li N (2014) Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation. J Thromb Haemost 12:1156\u20131165","journal-title":"J Thromb Haemost"},{"key":"2742_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/eci.12101","volume":"43","author":"KL Habets","year":"2013","unstructured":"Habets KL, Huizinga TW, Toes RE (2013) Platelets and autoimmunity. Eur J Clin Invest 43:746\u2013757","journal-title":"Eur J Clin Invest"},{"key":"2742_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5603\/EP.a2021.0059","volume":"72","author":"E Szczepanek-Parulska","year":"2021","unstructured":"Szczepanek-Parulska E, Adamska M, Korda O, Kosicka W, Skowronska D, Swiejkowska A et al (2021) Changes in complete blood count parameters influenced by endocrine disorders. Endokrynol Pol 72:261\u2013270","journal-title":"Endokrynol Pol"},{"key":"2742_CR20","first-page":"1687","volume":"49","author":"I Taskaldiran","year":"2019","unstructured":"Taskaldiran I, Omma T, Onder CE, Firat SN, Koc G, Kilic MK et al (2019) Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and platelet-tolymphocyte ratio in different etiological causes of thyrotoxicosis. Turk J Med Sci 49:1687\u20131692","journal-title":"Turk J Med Sci"},{"key":"2742_CR21","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/cells11111824","volume":"11","author":"A Margraf","year":"2022","unstructured":"Margraf A, Perretti M (2022) Immune cell plasticity in \u0131nflammation: \u0131nsights into description and regulation of \u0131mmune cell phenotypes. Cells 11:1824","journal-title":"Cells"},{"key":"2742_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/194542","volume":"2013","author":"P Naji","year":"2013","unstructured":"Naji P, Kumar G, Dewani S, Diedrich WA, Gupta A (2013) Graves\u2019 disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature. Case Rep Med 2013:194542","journal-title":"Case Rep Med"},{"key":"2742_CR23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.20452\/pamw.4079","volume":"127","author":"E Szczepanek-Parulska","year":"2017","unstructured":"Szczepanek-Parulska E, Hernik A, Rucha\u0142a M (2017) Anemia in thyroid diseases. Pol Arch Intern Med 127:352\u2013360","journal-title":"Pol Arch Intern Med"},{"key":"2742_CR24","first-page":"476","volume":"120","author":"E Turan","year":"2019","unstructured":"Turan E (2019) Evaluation of neutrophil-to-lymphocyte ratio and hematologic parameters in patients with Graves\u2019 disease. Bratisl Lek Listy 120:476\u2013480","journal-title":"Bratisl Lek Listy"},{"key":"2742_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12020-019-02137-y","volume":"67","author":"M Kim","year":"2020","unstructured":"Kim M, Kim BH, Jang MH, Kim MJ, Kim EH, Jeon YK et al (2020) High neutrophil-to-lymphocyte ratio is associated with relapse in Graves\u2019 disease after antithyroid drug therapy. Endocrine 67:406\u2013411","journal-title":"Endocrine"},{"key":"2742_CR26","first-page":"495","volume":"118","author":"T Celik","year":"2017","unstructured":"Celik T (2017) Neutrophil-to-lymphocyte ratio in thyroid ophthalmopathy. Bratisl Lek Listy 118:495\u2013498","journal-title":"Bratisl Lek Listy"},{"key":"2742_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3341\/kjo.2021.0012","volume":"35","author":"V Yeter","year":"2021","unstructured":"Yeter V, Kocak N, Arslan MT, Kan EK (2021) Blood count-derived Immunoinflammatory markers in thyroidassociated ophthalmopathy. Korean J Ophthalmol 35:198\u2013206","journal-title":"Korean J Ophthalmol"},{"key":"2742_CR28","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s10067-022-06122-1","volume":"41","author":"Y Xu","year":"2022","unstructured":"Xu Y, He H, Zang Y, Yu Z, Hu H, Cui J et al (2022) Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study. Clin Rheumatol 41:1989\u20132000","journal-title":"Clin Rheumatol"},{"key":"2742_CR29","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.3390\/jcm9103111","volume":"9","author":"J Szyde\u0142ko","year":"2020","unstructured":"Szyde\u0142ko J, Litwi\u0144czuk M, Szyde\u0142ko M, Matyjaszek-Matuszek B (2020) Neutrophil-to-lymphocyte, monocyte-to-lymphocyte and platelet-to-lymphocyte ratios in relation to clinical parameters and smoking status in patients with graves\u2019 orbitopathy-novel \u0131nsight into old tests. J Clin Med 9:3111","journal-title":"J Clin Med"},{"key":"2742_CR30","doi-asserted-by":"publisher","first-page":"9213074","DOI":"10.1155\/2019\/9213074","volume":"2019","author":"A Korniluk","year":"2019","unstructured":"Korniluk A, Koper-Lenkiewicz OM, Kami\u0144ska J, Kemona H, Dymicka-Piekarska V (2019) Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of \u0131nflammatory conditions. Mediators Inflamm 2019:9213074","journal-title":"Mediators Inflamm"},{"key":"2742_CR31","first-page":"165","volume":"65","author":"A Sahin","year":"2015","unstructured":"Sahin A, Yetisgin A, Sahin M, Durmaz Y, Cengiz AK (2015) can mean platelet volume be a surrogate marker of \u0131nflammation in rheumatic diseases? West Indian Med J 65:165\u2013169","journal-title":"West Indian Med J"},{"key":"2742_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/09537104.2015.1010441","volume":"26","author":"CN Jenne","year":"2015","unstructured":"Jenne CN, Kubes P (2015) Platelets in inflammation and infection. Platelets 26:286\u2013292","journal-title":"Platelets"},{"key":"2742_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1586\/17474086.2015.1069703","volume":"8","author":"G Lippi","year":"2015","unstructured":"Lippi G, Franchini M (2015) Platelets and immunity: the interplay of mean platelet volume in health and disease. Expert Rev Hematol 8:555\u2013557","journal-title":"Expert Rev Hematol"},{"key":"2742_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/bjo.88.1.72","volume":"88","author":"JM Kim","year":"2004","unstructured":"Kim JM, LaBree L, Levin L, Feldon SE (2004) The relation of Graves\u2019 ophthalmopathy to circulating thyroid hormone status. Br J Ophthalmol 88:72\u201374","journal-title":"Br J Ophthalmol"},{"key":"2742_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJM198701013160104","volume":"316","author":"TH Totterman","year":"1987","unstructured":"Totterman TH, Karlsson FA, Bengtsson M, Mendel-Hartvig I (1987) Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves\u2019 disease. N Engl J Med 316:15\u201322","journal-title":"N Engl J Med"},{"key":"2742_CR36","first-page":"361","volume":"62","author":"T Kuroki","year":"1985","unstructured":"Kuroki T, Ruf J, Whelan L, Miller A, Wall JR (1985) Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin Exp Immunol 62:361\u2013370","journal-title":"Clin Exp Immunol"},{"key":"2742_CR37","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/bjo.87.3.370","volume":"87","author":"N Kamminga","year":"2003","unstructured":"Kamminga N, Jansonius NM, Pott JWR, Links TP (2003) Unilateral proptosis: the role of medical history. Br J Ophthalmol 87:370\u2013371","journal-title":"Br J Ophthalmol"},{"key":"2742_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","volume":"38","author":"P Perros","year":"1993","unstructured":"Perros P, Crombie AL, Matthews JN, Kendall-Taylor P (1993) Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) 38:367\u2013372","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2742_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/thy.2007.0252","volume":"18","author":"JE Silva","year":"2008","unstructured":"Silva JE, Bianco SDC (2008) Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid 18:157\u2013165","journal-title":"Thyroid"},{"key":"2742_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/bjo.53.4.233","volume":"53","author":"JS Cant","year":"1969","unstructured":"Cant JS, Lewis DR, Harrison MT (1969) Treatment of dysthyroid ophthalmopathy with local guanethidine. Br J Ophthalmol 53:233\u2013238","journal-title":"Br J Ophthalmol"},{"key":"2742_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","volume":"269","author":"MF Prummel","year":"1993","unstructured":"Prummel MF, Wiersinga WM (1993) Smoking and risk of Graves\u2019 disease. JAMA 269:479\u2013482","journal-title":"JAMA"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02742-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02742-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02742-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T16:21:14Z","timestamp":1729441274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02742-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2742"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02742-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"7 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest and financial interest in any part of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}